BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 18807267)

  • 1. A nonsense mutation (E1978X) in the ATM gene is associated with breast cancer.
    Bogdanova N; Cybulski C; Bermisheva M; Datsyuk I; Yamini P; Hillemanns P; Antonenkova NN; Khusnutdinova E; Lubinski J; Dörk T
    Breast Cancer Res Treat; 2009 Nov; 118(1):207-11. PubMed ID: 18807267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the role of Finnish ataxia-telangiectasia mutations in hereditary predisposition to breast cancer.
    Pylkäs K; Tommiska J; Syrjäkoski K; Kere J; Gatei M; Waddell N; Allinen M; Karppinen SM; Rapakko K; Kääriäinen H; Aittomäki K; Blomqvist C; Mustonen A; Holli K; Khanna KK; Kallioniemi OP; Nevanlinna H; Winqvist R
    Carcinogenesis; 2007 May; 28(5):1040-5. PubMed ID: 17166884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATM allelic variants associated to hereditary breast cancer in 94 Chilean women: susceptibility or ethnic influences?
    Tapia T; Sanchez A; Vallejos M; Alvarez C; Moraga M; Smalley S; Camus M; Alvarez M; Carvallo P
    Breast Cancer Res Treat; 2008 Jan; 107(2):281-8. PubMed ID: 17351744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients.
    Dörk T; Bendix R; Bremer M; Rades D; Klöpper K; Nicke M; Skawran B; Hector A; Yamini P; Steinmann D; Weise S; Stuhrmann M; Karstens JH
    Cancer Res; 2001 Oct; 61(20):7608-15. PubMed ID: 11606401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between ataxia telangiectasia mutated gene polymorphisms and breast cancer in Taiwanese females.
    Wang HC; Chang WS; Tsai RY; Tsai CW; Liu LC; Su CH; Cheng HN; Tsou YA; Sun SS; Lin CC; Bau DT
    Anticancer Res; 2010 Dec; 30(12):5217-21. PubMed ID: 21187516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms of ataxia telangiectasia mutated and breast cancer risk.
    Lee KM; Choi JY; Park SK; Chung HW; Ahn B; Yoo KY; Han W; Noh DY; Ahn SH; Kim H; Wei Q; Kang D
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):821-5. PubMed ID: 15824150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two ATM variants and breast cancer risk.
    Thompson D; Antoniou AC; Jenkins M; Marsh A; Chen X; Wayne T; Tesoriero A; Milne R; Spurdle A; Thorstenson Y; Southey M; Giles GG; Khanna KK; Sambrook J; Oefner P; Goldgar D; Hopper JL; Easton D; Chenevix-Trench G;
    Hum Mutat; 2005 Jun; 25(6):594-5. PubMed ID: 15880680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATM germline mutations in women with familial breast cancer and a relative with haematological malignancy.
    Paglia LL; Laugé A; Weber J; Champ J; Cavaciuti E; Russo A; Viovy JL; Stoppa-Lyonnet D
    Breast Cancer Res Treat; 2010 Jan; 119(2):443-52. PubMed ID: 19404735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of mutations in ATM to breast cancer development in the Czech population.
    Soukupova J; Dundr P; Kleibl Z; Pohlreich P
    Oncol Rep; 2008 Jun; 19(6):1505-10. PubMed ID: 18497957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline ATM mutational analysis in BRCA1/BRCA2 negative hereditary breast cancer families by MALDI-TOF mass spectrometry.
    Graña B; Fachal L; Darder E; Balmaña J; Ramón Y Cajal T; Blanco I; Torres A; Lázaro C; Diez O; Alonso C; Santamariña M; Velasco A; Teulé A; Lasa A; Blanco A; Izquierdo A; Borràs J; Gutiérrez-Enríquez S; Vega A; Brunet J
    Breast Cancer Res Treat; 2011 Jul; 128(2):573-9. PubMed ID: 21445571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathological features of breast cancer in carriers of ATM gene variants.
    Balleine RL; Murali R; Bilous AM; Farshid G; Waring P; Provan P; Byth K; Thorne H; ; Kirk JA
    Histopathology; 2006 Nov; 49(5):523-32. PubMed ID: 17064299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of ATM gene mutations in young lung cancer patients: a population-based control study.
    Schneider J; Illig T; Rosenberger A; Bickeböller H; Wichmann HE
    Arch Med Res; 2008 Feb; 39(2):226-31. PubMed ID: 18164969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATM and breast cancer susceptibility.
    Ahmed M; Rahman N
    Oncogene; 2006 Sep; 25(43):5906-11. PubMed ID: 16998505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between polymorphisms of the ataxia telangiectasia mutated gene and breast cancer risk: evidence from the current studies.
    Lu PH; Wei MX; Si SP; Liu X; Shen W; Tao GQ; Chen MB
    Breast Cancer Res Treat; 2011 Feb; 126(1):141-8. PubMed ID: 20665102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of association between ATM C.1066-6T > G mutation and breast cancer risk: a meta-analysis of 8,831 cases and 4,957 controls.
    Ding H; Mao C; Li SM; Liu Q; Lin L; Chen Q
    Breast Cancer Res Treat; 2011 Jan; 125(2):473-7. PubMed ID: 20544271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATM gene founder haplotypes and associated mutations in Polish families with ataxia-telangiectasia.
    Mitui M; Bernatowska E; Pietrucha B; Piotrowska-Jastrzebska J; Eng L; Nahas S; Teraoka S; Sholty G; Purayidom A; Concannon P; Gatti RA
    Ann Hum Genet; 2005 Nov; 69(Pt 6):657-64. PubMed ID: 16266405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The BARD1 Cys557Ser variant and breast cancer risk in Iceland.
    Stacey SN; Sulem P; Johannsson OT; Helgason A; Gudmundsson J; Kostic JP; Kristjansson K; Jonsdottir T; Sigurdsson H; Hrafnkelsson J; Johannsson J; Sveinsson T; Myrdal G; Grimsson HN; Bergthorsson JT; Amundadottir LT; Gulcher JR; Thorsteinsdottir U; Kong A; Stefansson K
    PLoS Med; 2006 Jul; 3(7):e217. PubMed ID: 16768547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The breast cancer susceptibility mutation PALB2 1592delT is associated with an aggressive tumor phenotype.
    Heikkinen T; Kärkkäinen H; Aaltonen K; Milne RL; Heikkilä P; Aittomäki K; Blomqvist C; Nevanlinna H
    Clin Cancer Res; 2009 May; 15(9):3214-22. PubMed ID: 19383810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High frequency and allele-specific differences of BRCA1 founder mutations in breast cancer and ovarian cancer patients from Belarus.
    Bogdanova NV; Antonenkova NN; Rogov YI; Karstens JH; Hillemanns P; Dörk T
    Clin Genet; 2010 Oct; 78(4):364-72. PubMed ID: 20569256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Ser49Cys variant in the ataxia telangiectasia, mutated, gene that is more common in patients with breast carcinoma compared with population controls.
    Buchholz TA; Weil MM; Ashorn CL; Strom EA; Sigurdson A; Bondy M; Chakraborty R; Cox JD; McNeese MD; Story MD
    Cancer; 2004 Apr; 100(7):1345-51. PubMed ID: 15042666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.